About Dr Roderick Clifton-Bligh

Clinical research is the coal-face of clinical medicine and has direct benefits for patients I care for every day.

Rory Clifton-Bligh is an endocrinologist with primary interests in thyroid cancer and metabolic bone disease research.

Dr Clifton-Bligh undertook doctoral studies into the molecular mechanisms of thyroid growth and function, with Professor VKK Chatterjee at the University of Cambridge. Since returning to Sydney, he has maintained an active involvement in both basic and clinical research projects, in conjunction with a busy clinical practice. He now directs research programs on mechanisms of thyroid cancer development; and on clinical and basic aspects of calcium, vitamin D and phosphate regulation. He has established genetic testing for several endocrine conditions (familial hypocalciuric hypercalcaemia, autosomal dominant hypocalcaemia, thyroid hormone resistance, TSH resistance) and receives referrals from around Australia and New Zealand for genetic diagnosis of these conditions. He has co-authored three book chapters in addition to his publications in peer-reviewed journals. He has given three invited lectures at International meetings. Dr Clifton-Bligh has co-supervised two completed PhDs and is currently co-supervising three PhD students within the laboratory of Professor B Robinson. He has a very strong interest in both under-graduate and post-graduate medical teaching. Grant support has included Northern Area Health Research grants for studying the function of 1-alpha hydroxylase in disorders of mineral ion homeostasis (2002) and the role of FGF23 (phosphatonin) in myeloma bone disease (2004); from Leo and Jenny Leukaemia and Cancer Foundation to study novel fusion oncoproteins in follicular thyroid carcinoma (2002); from the University of Sydney Sesqui Grant scheme using a novel dominant negative receptor to investigate tissue-specific calcium signalling in bone (2002); from the Lincoln Centre to establish a mouse model of impaired amino-acid signalling via the calcium-sensing receptor (2004); and the University of Sydney Cancer Research Fund to study novel fusion oncoproteins in Follicular Thyroid Carcinoma (2003).

Selected publications

For a comprehensive list of Dr Clifton-Bligh's publicatons, please visit his Sydney Medical School profile page.